US Centers for Medicare & Medicaid Services to Recognize CGMs for Treatment Decisions in Diabetes

Date: 
January, 2017
January 12, 2017. The US Centers for Medicare & Medicaid Services (CMS) has released a determination that continuous glucose monitoring (CGM) devices are now classified as "durable medical equipment," making them eligible for CMS coverage on a case-by-case basis. Most private payers already provide coverage for CGM devices, and multiple national guidelines recommend their use. Click here for full article